ArticleCurrent neuropharmacology2023

Tumor-selective Blockade of CD47 Signaling with CD47 Antibody for Enhanced Anti-tumor Activity in Malignant Meningioma.

Xiaotong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.